AusBiotech expands investment attraction portfolio

AusBiotech has announced an expanded investment attraction, commenced in line with a new investment attraction strategy....

July 12, 2022 | Tuesday | News
Australia uses machine learning to provide early warning for emerging COVID-19 variants

Researchers at the Commonwealth Scientific and Industrial Research Organisation (CSIRO), Australia’s national scie...

July 11, 2022 | Monday | News
Australia uncovers driving forces of Alzheimer’s disease

Alzheimer’s disease, the most common form of dementia, currently has no cure or effective therapy, in part due to ...

July 8, 2022 | Friday | News
harrison.ai & Sonic Healthcare join forces to bring AI to pathology in Australia

Australia-based harrison.ai, a clinically led healthcare AI platform and Sonic Healthcare, the global medical diagn...

July 7, 2022 | Thursday | News
Australian scientists provide insights into colon cancer prevention

Scientists in Australia have isolated five strains of gut bacteria that could pave the way for new inflammatory bowel di...

July 6, 2022 | Wednesday | News
ResApp Health receives US FDA clearance for at-home sleep test

Australian firm ResApp Health, a leading digital health company developing smartphone applications for the diagnosis and...

July 6, 2022 | Wednesday | News
“ATH434 has the potential to address the underlying pathology of Multiple System Atrophy”

In conversation with BioSpectrum Asia, Dr David Stamler, Chief Executive Officer, Alterity Therapeutics reveals more abo...

July 5, 2022 | Tuesday | Opinion
Australia invests $220 M to support aged care facilities

The Australian Government is investing $106 million to provide face-to-face support for older First Nations people and $...

July 5, 2022 | Tuesday | News
Australia explores deadly spider venom treatment for heart attacks with $23M funding

A potentially life-saving treatment containing venom from one of the world’s deadliest spiders is one step closer ...

July 4, 2022 | Monday | News
Australia's EnGeneIC brings 2nd-Gen COVID-19 vaccine against all variants

Australian biopharma company EnGeneIC is developing the world’s first COVID-19 vaccine which can offer immunity ag...

June 29, 2022 | Wednesday | News
Third wave of COVID-19 delivers highest mortality risk in Australian ICUs

According to a new study led by Monash University, of those admitted to the intensive care unit (ICU) with COVID-19, aft...

June 28, 2022 | Tuesday | News
Australia's Noxopharm receives A$1.45M grant for inflammation-based research

Australian biotech firm Noxopharm has announced that the Victorian Government has granted A$1.45M to Noxopharm collabora...

June 27, 2022 | Monday | News
Australia develops new solution for stem cell manufacturing

Researchers at University of Technology Sydney have developed a unique 3D printed system for harvesting stem cells from ...

June 23, 2022 | Thursday | News
Australia calls for urgent review on vaccines during pregnancy

Australia's University of Queensland (UQ) researchers are calling for an urgent review of low influenza vaccination rate...

June 20, 2022 | Monday | News
Medtech firm Hyperfine announces expansion into Australia and New Zealand

US-based Hyperfine Inc., creator of the Swoop Portable MR Imaging System, the world’s first US FDA-cleared portabl...

June 21, 2022 | Tuesday | News
Government invests $143.3M in Sydney Biomedical Accelerator

The University of Sydney has announced that the New South Wales (NSW) government is providing $143.3 million over four...

June 17, 2022 | Friday | News
Australia develops digital tool to give surgeons a pre-theatre rehearsal

Researchers at Australia-based University of Sydney’s School of Aerospace, Mechanical and Mechatronic Enginee...

June 14, 2022 | Tuesday | News
Australia’s mRNA projects receive funding boost

Two Monash University projects using mRNA delivery to improve treatments for people with muscular dystrophy or metabolic...

June 13, 2022 | Monday | News